Phase 2 trial data showed average weight loss of up to 24.2% at 48 weeks, while the newer Phase 3 trial data showed 28.7% average weight loss at 68 weeks on the 12mg dose
Unlike fad diets or quick fixes, Semaglutide addresses the underlying biological factors that make weight loss challenging
Discuss your full medical history with a provider before starting
A headache that will not clear with oral fluids and rest, especially with vomiting or illness, often resolves quickly once fluids are replaced
Note that not all studies show similar results
Stubborn weight & visceral fat Insulin resistance & prediabetes Constant hunger & food noise Plateaus despite diet & exercise Inflammation & metabolic syndrome Energy crashes & poor recovery What we offer GLP-1 and peptide options The right molecule depends on your goals, your labs, and your history